Nano-Biotechnology for Bacteria Identification and Potent Anti-bacterial Properties: A Review of Current State of the Art
- PMID: 37764558
- PMCID: PMC10536455
- DOI: 10.3390/nano13182529
Nano-Biotechnology for Bacteria Identification and Potent Anti-bacterial Properties: A Review of Current State of the Art
Abstract
Sepsis is a critical disease caused by the abrupt increase of bacteria in human blood, which subsequently causes a cytokine storm. Early identification of bacteria is critical to treating a patient with proper antibiotics to avoid sepsis. However, conventional culture-based identification takes a long time. Polymerase chain reaction (PCR) is not so successful because of the complexity and similarity in the genome sequence of some bacterial species, making it difficult to design primers and thus less suitable for rapid bacterial identification. To address these issues, several new technologies have been developed. Recent advances in nanotechnology have shown great potential for fast and accurate bacterial identification. The most promising strategy in nanotechnology involves the use of nanoparticles, which has led to the advancement of highly specific and sensitive biosensors capable of detecting and identifying bacteria even at low concentrations in very little time. The primary drawback of conventional antibiotics is the potential for antimicrobial resistance, which can lead to the development of superbacteria, making them difficult to treat. The incorporation of diverse nanomaterials and designs of nanomaterials has been utilized to kill bacteria efficiently. Nanomaterials with distinct physicochemical properties, such as optical and magnetic properties, including plasmonic and magnetic nanoparticles, have been extensively studied for their potential to efficiently kill bacteria. In this review, we are emphasizing the recent advances in nano-biotechnologies for bacterial identification and anti-bacterial properties. The basic principles of new technologies, as well as their future challenges, have been discussed.
Keywords: anti-bacterial activity; antimicrobial resistance; bacteria identification; nanotechnology; sepsis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures







Similar articles
-
Sepsis Management, Controversies, and Advancement in Nanotechnology: A Systematic Review.Cureus. 2022 Feb 11;14(2):e22112. doi: 10.7759/cureus.22112. eCollection 2022 Feb. Cureus. 2022. PMID: 35308665 Free PMC article. Review.
-
Deploying Gold Nanomaterials in Combating Multi-Drug-Resistant Bacteria.ACS Nano. 2022 Jul 26;16(7):10066-10087. doi: 10.1021/acsnano.2c02269. Epub 2022 Jul 1. ACS Nano. 2022. PMID: 35776694 Review.
-
Nano-enabled sensing approaches for pathogenic bacterial detection.Biosens Bioelectron. 2020 Oct 1;165:112276. doi: 10.1016/j.bios.2020.112276. Epub 2020 May 19. Biosens Bioelectron. 2020. PMID: 32729465 Review.
-
Advances in sepsis diagnosis and management: a paradigm shift towards nanotechnology.J Biomed Sci. 2021 Jan 8;28(1):6. doi: 10.1186/s12929-020-00702-6. J Biomed Sci. 2021. PMID: 33413364 Free PMC article. Review.
-
Recent advances in nanomaterial-based biosensors for antibiotics detection.Biosens Bioelectron. 2017 May 15;91:504-514. doi: 10.1016/j.bios.2017.01.007. Epub 2017 Jan 5. Biosens Bioelectron. 2017. PMID: 28082239 Review.
Cited by
-
Nanotechnology's frontier in combatting infectious and inflammatory diseases: prevention and treatment.Signal Transduct Target Ther. 2024 Feb 21;9(1):34. doi: 10.1038/s41392-024-01745-z. Signal Transduct Target Ther. 2024. PMID: 38378653 Free PMC article. Review.
-
Advancing foodborne pathogen detection: a review of traditional and innovative optical and electrochemical biosensing approaches.Mikrochim Acta. 2025 Jan 22;192(2):102. doi: 10.1007/s00604-024-06924-x. Mikrochim Acta. 2025. PMID: 39843762 Review.
-
Phenotypic and genotypic perspectives on detection methods for bacterial antimicrobial resistance in a One Health context: research progress and prospects.Arch Microbiol. 2024 Sep 20;206(10):409. doi: 10.1007/s00203-024-04131-z. Arch Microbiol. 2024. PMID: 39302440 Review.
References
-
- Rubio I., Osuchowski M.F., Shankar-Hari M., Skirecki T., Winkler M.S., Lachmann G., La Rosée P., Monneret G., Venet F., Bauer M., et al. Current gaps in sepsis immunology: New opportunities for translational research. Lancet Infect. Dis. 2019;19:e422–e436. doi: 10.1016/S1473-3099(19)30567-5. - DOI - PubMed
-
- Weiss S.L., Peters M.J., Alhazzani W., Agus M.S.D., Flori H.R., Inwald D.P., Nadel S., Schlapbach L.J., Tasker R.C., Argent A.C., et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Med. 2020;46:10–67. doi: 10.1007/s00134-019-05878-6. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources